A Heurtier - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

A Heurtier

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Journal of Immunology (Baltimore, Md. : 1950)|June 22, 2000

Systemic administration of agonist peptide blocks the progression of spontaneous CD8-mediated autoimmune diabetes in transgenic mice without bystander damageN Bercovici, A Heurtier, C Vizler, et al.

Journal of Immunology (Baltimore, Md. : 1950)|November 22, 2000

Relative diabetogenic properties of islet-specific Tc1 and Tc2 cells in immunocompetent hostsC Vizler, N Bercovici, A Heurtier, et al.

Diabetes & Metabolism|February 1, 1997

[Hypoglycemia in the diabetic patient. Recommendations of ALFEDIAM]A Grimaldi, G Slama, N Tubiana-Rufi, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Journal of Immunology (Baltimore, Md. : 1950)|June 22, 2000

Systemic administration of agonist peptide blocks the progression of spontaneous CD8-mediated autoimmune diabetes in transgenic mice without bystander damageN Bercovici, A Heurtier, C Vizler, et al.

Journal of Immunology (Baltimore, Md. : 1950)|November 22, 2000

Relative diabetogenic properties of islet-specific Tc1 and Tc2 cells in immunocompetent hostsC Vizler, N Bercovici, A Heurtier, et al.

Diabetes & Metabolism|February 1, 1997

[Hypoglycemia in the diabetic patient. Recommendations of ALFEDIAM]A Grimaldi, G Slama, N Tubiana-Rufi, et al.

Pageof 2